India's Serum Institute to boost vaccine exports gradually, report says

The Serum Institute of India, which produces the AstraZeneca COVID-19 vaccine, will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by January, its head told The Telegraph.

migrator

Updated:1st Oct, 2021 at 1:57 PM

New Delhi

"Our exports to COVAX will recommence again in October, initially these supplies will be small but by January 2022, once we have satisfied domestic demands – people forget that India is still a lower-middle-income country – we will see large volumes go to COVAX," Chief Executive Adar Poonawalla said.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

India's Serum Institute to boost vaccine exports gradually, report says

The Serum Institute of India, which produces the AstraZeneca COVID-19 vaccine, will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by January, its head told The Telegraph.

Also Read

E20 policy-reality gap: Public distrustful of government's push for ethanol in petrol, finds Coimbatore study

Free Wi-Fi at Chennai beaches from September; visitors demand stable service

Tambaram: Sanitation workers boycott work over low wages, PF dues

Nationwide tests find E20 petrol meets quality norms, say oil companies rejecting contamination claims

Chennai Citizen Connect: Commuters in a fix as parking for Aadhaar office spills onto bus bay in Anna Nagar